S100A11P6

Across TCGA pan-cancer cohorts, S100A11P6 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of S100A11P6’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where S100A11P6 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types S100A11P6 is over-expressed in tumor.

LIHC, HNSC, and LUSC are the cancer types where S100A11P6 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in S100A11P6 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	All	+0.158	.014	2	view →
HNSC	All	II,III,IV	+0.155	.029	2	view →
LUSC	Male	All	+0.094	.007	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

S100A11P6–LIHC

Open the LIHC breakdown →